通过干预措施系统综述中的扩展核对表评估 PRISMA 2020 声明的遵守情况:荟萃流行病学研究

Diego Ivaldi, Mariana Burgos, Gisela Oltra, Camila E. Liquitay, Luis Garegnani
{"title":"通过干预措施系统综述中的扩展核对表评估 PRISMA 2020 声明的遵守情况:荟萃流行病学研究","authors":"Diego Ivaldi,&nbsp;Mariana Burgos,&nbsp;Gisela Oltra,&nbsp;Camila E. Liquitay,&nbsp;Luis Garegnani","doi":"10.1002/cesm.12074","DOIUrl":null,"url":null,"abstract":"<div>\n \n \n <section>\n \n <h3> Introduction</h3>\n \n <p>The preferred reporting items for systematic reviews and meta-analyses (PRISMA) statement was developed to improve the reporting of systematic reviews (SRs) and meta-analyses. Due to the suboptimal reporting of the 2009 version, an update was performed and published in 2021. Despite having been evaluated in studies published before its publication, its adherence in SRs of interventions published after 2021 remains unclear.</p>\n </section>\n \n <section>\n \n <h3> Objective</h3>\n \n <p>To assess PRISMA 2020 statement adherence and its uptake in SRs of interventions.</p>\n </section>\n \n <section>\n \n <h3> Methods</h3>\n \n <p>We conducted a prospective cross-sectional study searching MEDLINE (PubMed), including a 10% random sample of all SRs involving human interventions published since January 2022 retrieved by our search process. We did not apply any restrictions. We assessed PRISMA 2020 statement uptake and its adherence using its expanded checklist.</p>\n </section>\n \n <section>\n \n <h3> Results</h3>\n \n <p>We included 222 out of 945 studies. 67 (30.18%) used PRISMA 2020 statement. None adhered completely, with an average adherence of 42.64% (Min–Max: 14.29%–76.19%). Results and Methods sections had low adherence, with 40.57% (Min–Max: 10.45%–98.51%) and 25.55% (Min–Max: 7.46%–55.22%) respectively. The items with the least adherence were: certainty and reporting bias assessment, excluded studies characteristics and search strategy with 7.46% (5/67), 8.96% (6/67), 10.45% (7/67), and 11.94% (8/67) respectively.</p>\n </section>\n \n <section>\n \n <h3> Discussion</h3>\n \n <p>As in previous studies, our study showed low adherence, mainly to the methods and results sections. However, our study showed a lower adherence, probably due to the use of the expanded checklist to assessed the tools adherence.</p>\n </section>\n \n <section>\n \n <h3> Conclusion</h3>\n \n <p>We found a low adherence rate to the PRISMA 2020 expanded checklist. Further PRISMA dissemination and targeted audience training are needed to improve SR reporting and quality.</p>\n </section>\n </div>","PeriodicalId":100286,"journal":{"name":"Cochrane Evidence Synthesis and Methods","volume":"2 5","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-05-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/cesm.12074","citationCount":"0","resultStr":"{\"title\":\"Adherence to PRISMA 2020 statement assessed through the expanded checklist in systematic reviews of interventions: A meta-epidemiological study\",\"authors\":\"Diego Ivaldi,&nbsp;Mariana Burgos,&nbsp;Gisela Oltra,&nbsp;Camila E. Liquitay,&nbsp;Luis Garegnani\",\"doi\":\"10.1002/cesm.12074\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div>\\n \\n \\n <section>\\n \\n <h3> Introduction</h3>\\n \\n <p>The preferred reporting items for systematic reviews and meta-analyses (PRISMA) statement was developed to improve the reporting of systematic reviews (SRs) and meta-analyses. Due to the suboptimal reporting of the 2009 version, an update was performed and published in 2021. Despite having been evaluated in studies published before its publication, its adherence in SRs of interventions published after 2021 remains unclear.</p>\\n </section>\\n \\n <section>\\n \\n <h3> Objective</h3>\\n \\n <p>To assess PRISMA 2020 statement adherence and its uptake in SRs of interventions.</p>\\n </section>\\n \\n <section>\\n \\n <h3> Methods</h3>\\n \\n <p>We conducted a prospective cross-sectional study searching MEDLINE (PubMed), including a 10% random sample of all SRs involving human interventions published since January 2022 retrieved by our search process. We did not apply any restrictions. We assessed PRISMA 2020 statement uptake and its adherence using its expanded checklist.</p>\\n </section>\\n \\n <section>\\n \\n <h3> Results</h3>\\n \\n <p>We included 222 out of 945 studies. 67 (30.18%) used PRISMA 2020 statement. None adhered completely, with an average adherence of 42.64% (Min–Max: 14.29%–76.19%). Results and Methods sections had low adherence, with 40.57% (Min–Max: 10.45%–98.51%) and 25.55% (Min–Max: 7.46%–55.22%) respectively. The items with the least adherence were: certainty and reporting bias assessment, excluded studies characteristics and search strategy with 7.46% (5/67), 8.96% (6/67), 10.45% (7/67), and 11.94% (8/67) respectively.</p>\\n </section>\\n \\n <section>\\n \\n <h3> Discussion</h3>\\n \\n <p>As in previous studies, our study showed low adherence, mainly to the methods and results sections. However, our study showed a lower adherence, probably due to the use of the expanded checklist to assessed the tools adherence.</p>\\n </section>\\n \\n <section>\\n \\n <h3> Conclusion</h3>\\n \\n <p>We found a low adherence rate to the PRISMA 2020 expanded checklist. Further PRISMA dissemination and targeted audience training are needed to improve SR reporting and quality.</p>\\n </section>\\n </div>\",\"PeriodicalId\":100286,\"journal\":{\"name\":\"Cochrane Evidence Synthesis and Methods\",\"volume\":\"2 5\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-05-23\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://onlinelibrary.wiley.com/doi/epdf/10.1002/cesm.12074\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Cochrane Evidence Synthesis and Methods\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1002/cesm.12074\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cochrane Evidence Synthesis and Methods","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/cesm.12074","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

导言 系统综述和荟萃分析的首选报告项目(PRISMA)声明是为了改进系统综述(SR)和荟萃分析的报告而制定的。由于 2009 年版本的报告效果不佳,我们对其进行了更新,并于 2021 年出版。尽管在该版本发布前已对发表的研究进行了评估,但在 2021 年后发表的干预措施 SR 中,该版本的遵守情况仍不明确。 目的 评估 PRISMA 2020 声明的遵守情况及其在干预SR中的应用情况。 方法 我们进行了一项前瞻性横断面研究,搜索了 MEDLINE (PubMed),包括搜索过程中检索到的自 2022 年 1 月以来发表的所有涉及人类干预的 SR,随机抽样 10%。我们没有施加任何限制。我们使用扩展检查表评估了 PRISMA 2020 声明的采纳情况及其遵守情况。 结果 我们纳入了 945 项研究中的 222 项。67项(30.18%)使用了PRISMA 2020声明。没有一项完全遵守,平均遵守率为 42.64%(最小值-最大值:14.29%-76.19%)。结果和方法部分的遵守率较低,分别为 40.57%(最小值-最大值:10.45%-98.51%)和 25.55%(最小值-最大值:7.46%-55.22%)。坚持率最低的项目是:确定性和报告偏倚评估、排除研究特征和检索策略,分别为 7.46%(5/67)、8.96%(6/67)、10.45%(7/67)和 11.94%(8/67)。 讨论 与之前的研究一样,我们的研究也显示出较低的依从性,主要是对方法和结果部分的依从性较低。然而,我们的研究显示出较低的依从性,这可能是由于使用了扩展核对表来评估工具的依从性。 结论 我们发现 PRISMA 2020 扩展核对表的遵循率较低。需要进一步推广 PRISMA 并对受众进行有针对性的培训,以提高 SR 报告的质量。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

Adherence to PRISMA 2020 statement assessed through the expanded checklist in systematic reviews of interventions: A meta-epidemiological study

Adherence to PRISMA 2020 statement assessed through the expanded checklist in systematic reviews of interventions: A meta-epidemiological study

Introduction

The preferred reporting items for systematic reviews and meta-analyses (PRISMA) statement was developed to improve the reporting of systematic reviews (SRs) and meta-analyses. Due to the suboptimal reporting of the 2009 version, an update was performed and published in 2021. Despite having been evaluated in studies published before its publication, its adherence in SRs of interventions published after 2021 remains unclear.

Objective

To assess PRISMA 2020 statement adherence and its uptake in SRs of interventions.

Methods

We conducted a prospective cross-sectional study searching MEDLINE (PubMed), including a 10% random sample of all SRs involving human interventions published since January 2022 retrieved by our search process. We did not apply any restrictions. We assessed PRISMA 2020 statement uptake and its adherence using its expanded checklist.

Results

We included 222 out of 945 studies. 67 (30.18%) used PRISMA 2020 statement. None adhered completely, with an average adherence of 42.64% (Min–Max: 14.29%–76.19%). Results and Methods sections had low adherence, with 40.57% (Min–Max: 10.45%–98.51%) and 25.55% (Min–Max: 7.46%–55.22%) respectively. The items with the least adherence were: certainty and reporting bias assessment, excluded studies characteristics and search strategy with 7.46% (5/67), 8.96% (6/67), 10.45% (7/67), and 11.94% (8/67) respectively.

Discussion

As in previous studies, our study showed low adherence, mainly to the methods and results sections. However, our study showed a lower adherence, probably due to the use of the expanded checklist to assessed the tools adherence.

Conclusion

We found a low adherence rate to the PRISMA 2020 expanded checklist. Further PRISMA dissemination and targeted audience training are needed to improve SR reporting and quality.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信